Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04515238
What this trial is testing

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

Who this might be right for
Chronic Lymphoid Leukemia
German CLL Study Group 42
Early research (Phase 1)Ended earlyNCT04033458
What this trial is testing

JNJ-64140284 Solid Dose Formulations in Healthy Male Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 1
Testing effectiveness (Phase 2)Ended earlyNCT04524858
What this trial is testing

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

Who this might be right for
Cryopyrin-Associated Periodic Syndrome
Aclaris Therapeutics, Inc. 1
Large-scale testing (Phase 3)Study completedNCT00296855
What this trial is testing

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

Who this might be right for
Peripheral Vascular Diseases
Bayer 261
Testing effectiveness (Phase 2)UnknownNCT05840835
What this trial is testing

Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Immix Biopharma, Inc. 60
Post-approval studies (Phase 4)Study completedNCT00181935
What this trial is testing

Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder

Who this might be right for
Bipolar DisorderMania
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01397708
What this trial is testing

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 26
Early research (Phase 1)Ended earlyNCT03894540
What this trial is testing

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor
Ipsen 22
Testing effectiveness (Phase 2)Study completedNCT00190840
What this trial is testing

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company 186
Early research (Phase 1)Study completedNCT03306589
What this trial is testing

Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 12
Large-scale testing (Phase 3)Ended earlyNCT02245568
What this trial is testing

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Who this might be right for
Alzheimer's DiseaseBehavioral Variant Frontotemporal Dementia
TauRx Therapeutics Ltd 913
Early research (Phase 1)Study completedNCT06491550
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 91
Large-scale testing (Phase 3)Study completedNCT02057250
What this trial is testing

To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis

Who this might be right for
RA
Sanofi 217
Testing effectiveness (Phase 2)WithdrawnNCT03187691
What this trial is testing

Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Matinas BioPharma Nanotechnologies, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT07213674
What this trial is testing

Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 750
Early research (Phase 1)Looking for participantsNCT07632274
What this trial is testing

Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years

Who this might be right for
Pain
HALEON 12
Testing effectiveness (Phase 2)Study completedNCT02501018
What this trial is testing

Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)

Who this might be right for
Critical Limb IschemiaBuerger DiseaseThromboangiitis Obliterans+1 more
Lisata Therapeutics, Inc. 33
Large-scale testing (Phase 3)Study completedNCT05802290
What this trial is testing

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Gruppo Oncologico del Nord-Ovest 124
Testing effectiveness (Phase 2)Ended earlyNCT04066790
What this trial is testing

Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 12
Testing effectiveness (Phase 2)UnknownNCT03562390
What this trial is testing

Irinotecan for Advanced and Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Liaoning Cancer Hospital & Institute 124
Next Page